The tumour–stroma ratio in colon cancer: the biological role and its prognostic impact
- 19 February 2018
- journal article
- review article
- Published by Wiley in Histopathology
- Vol. 73 (2) , 197-206
Abstract
The tumour microenvironment consists of a complex mixture of non‐neoplastic cells, including fibroblasts, immune cells and endothelial cells embedded in the proteins of the extracellular matrix. The tumour microenvironment plays an active role in tumour behaviour. By interacting with cancer cells, it influences disease progression and the metastatic capacity of the tumour. Tumours with a high amount of stroma correspond to poor patient prognosis. The tumour–stroma ratio (TSR) is a strong independent prognostic tool in colon cancer and provides additional value to the current clinically used tumour–node–metastasis classification. The TSR is assessed on conventional haematoxylin and eosin‐stained paraffin sections at the invasive front of the tumour. Here we review studies demonstrating the prognostic significance of the TSR in solid epithelial tumours with a focus on colon cancer. Moreover, the biological role of the tumour microenvironment during tumour progression and invasion will be discussed, as well as the attempts to target the tumour stroma for therapeutic purposes. We suggest that the TSR can be implemented with little effort and without additional costs in current routine pathology diagnostics owing to its simplicity and reliability.Keywords
This publication has 55 references indexed in Scilit:
- Is the prediction of prognosis not improved by the seventh edition of the TNM classification for colorectal cancer? Analysis of the surveilla006Ece, epidemiology, and end results (SEER) databaseBMC Cancer, 2013
- Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis InitiationCancer Cell, 2012
- The prognostic value of tumour-stroma ratio in triple-negative breast cancerEuropean Journal of Surgical Oncology, 2012
- Single-cell dissection of transcriptional heterogeneity in human colon tumorsNature Biotechnology, 2011
- Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsiesEuropean Journal of Cancer, 2011
- The proportion of tumour cells is an independent predictor for survival in colorectal cancer patientsBritish Journal of Cancer, 2010
- Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patientsBreast Cancer Research and Treatment, 2010
- The stromal part of adenocarcinomas of the oesophagus: Does it conceal targets for therapy?European Journal of Cancer, 2010
- Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)Breast Cancer Research and Treatment, 2010
- Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviourThe Journal of Pathology, 2004